MCE 的所有產品僅用作科學研究或藥證申報，我們不為任何個人用途提供產品和服務。

BIIE-0246

CAS No. : 246146-55-4

產品活性：BIIE-0246 is a potent and highly selective non-peptide neuropeptide Y (NPY) Y₂ receptor antagonist, with an IC₅₀ of 15 nM.

研究領域：GPCR/G Protein  |  Neuronal Signaling

作用靶點：Neuropeptide Y Receptor

In Vitro: Receptor binding assays in HEK 293 cells transfected with the rat Y2 receptor cDNA demonstrate that BIIE-0246 competes with high affinity (IC₅₀=15±3 nM) against specific [¹²⁵I]PYY_3-36 binding sites. In contrast, BIIE-0246, at concentrations up to 10 μM, fails to compete for significant amounts of specific [¹²⁵I]GR231118, [¹²⁵I]hPP and [¹²⁵I][Leu³¹, Pro³⁴]PYY binding sites in HEK 293 cells transfected with the rat Y₁, Y₄ or Y₅ receptor cDNA, respectively.

In Vivo: On chow diet, genetically obese NPY mice show increased gain in body weight and adiposity. Treatment with BIIE-0246 promotes body weight gain in both genotypes after 4.5 weeks, and already at 2 weeks. BIIE-0246 has no significant effect on fat mass gain. In DIO, BIIE-0246 has different effects on body weight and composition depending on the genotype (treatment×genotype interaction in body weight P<0.05, in fat mass P<0.001 and in lean mass P<0.05). In DIO-WT group, post hoc analysis reveals increased body weight and fat mass gain, and a tendency to decrease lean mass gain. In DIO-NPY, BIIE-0246 inhibits fat mass gain (P=0.05). Interestingly, increased cholesterol levels are detected also in WT mice treated with BIIE-0246 for 2 weeks, but not in the 4.5-week cohort. In DIO-NPY mice in both treatment groups, cholesterol levels correlate positively with body fat mass (DIO-NPY vehicle P<0.01; DIO-NPY BIIE-0246 P<0.001), but not in any other group, and the slope of the regression curve of cholesterol and fat mass is significantly decreased in BIIE-0246-treated DIO-NPY group when compared with vehicle-treated group.

相關產品：Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Neuronal Signaling Compound Library  |  Anti-diabetic Compound Library  |  Endocrinology Compound Library  |  Neurotransmitter Receptor Compound Library  |  Anti-Obesity Compound Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Neuropeptide Y (3-36) (porcine)  |  CART(55-102)(rat)  |  Galanin (1-16), mouse, porcine, rat  |  RFRP-1(human) TFA  |  Spexin  |  Galanin Receptor Ligand M35 TFA  |  RFRP-1(human)  |  CART(55-102)(human)  |  RTI-118  |  RF9  |  [Leu31,Pro34]-Neuropeptide Y(human,rat) TFA  |  SF 11  |  RFRP-3(human) TFA  |  M1145 TFA  |  (Leu31,Pro34)-Peptide YY (human)  |  Galantide  |  CYM 9484  |  Neuropeptide Y (18-36) (porcine)  |  Neuropeptide Y (human) (TFA)  |  NTNCB hydrochloride  |  M40  |  Neuropeptide S(Rat) TFA  |  FR252384  |  BIBP3226

熱門產品線：重組蛋白  |  化合物庫  |  天然產物  |  熒光染料  |  PROTAC  |  同位素標記物  |  寡核苷酸  |  抗體  |  點擊化學

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介紹:
•   MCE (MedChemExpress) 擁有200 多種*僅有化合物庫，我們致力于為*科研客戶提供前沿的高品質小分子活性化合物；
•   50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領；
•   產品種類涵蓋各種重組蛋白，多肽，常用試劑盒 ，更有 PROTAC、ADC 等特色產品，廣泛應用于新藥研發、生命科學等科研項目；
•   提供虛擬篩選，離子通道篩選，代謝組學分析檢測分析，藥物篩選等專業技術服務；
•   設有專業的實驗中心和嚴格的質控、驗證體系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質檢報告，確保產品的高純度、高品質；
•   產品的生物活性多經各國客戶實驗驗證；
•   Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果；
•   專業團隊跟蹤新的制藥及生命科學研究進展，為您提供*新的活性化合物；
•   與世界各大制藥公司及*科研機構建立了長期的合作。